India's pharmaceutical sector, renowned for its cheap medications and broad manufacturing capabilities, faces a growing concern: monopolies. While generic drug production has been a cornerstone of India's achievement, certain companies have emerged with dominant market shares, potentially impeding access to essential drugs and driving up prices.